Company intelligence / Profile preview

Bionance

Phoenix, Arizona, United States

Ownership: Private
Development stage: Other

Overview

Bionance is a specialized financial services and investment firm focused on the medical and healthcare sectors. Established in 2025 as a joint venture by Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), the company provides strategic capital solutions, including growth capital lending and structured credit, to publicly traded medical companies. Bionance leverages the clinical and industry expertise of its parent company to identify and fund innovative healthcare ventures, aiming to fuel long-term growth and operational expansion. The firm's activities include investing in convertible notes and warrants of emerging biotechnology and medical technology companies, such as Applife Digital Solutions.

Industry: Investors

Partnerships

Applife Digital Solutions

Beyond the preview

Go deeper on Bionance.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bionance.

Explore the full profile